Latest News and Press Releases
Want to stay updated on the latest news?
-
MELBOURNE, Australia, July 19, 2019 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP) (“Cynata” or, the “Company”), a clinical-stage biotechnology company specializing in cell therapeutics,...
-
MELBOURNE, Australia, March 12, 2019 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that...
-
MELBOURNE, Australia, Dec. 18, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specializing in cell therapeutics, is pleased to announce that...
-
NHMRC to Fund Major Phase 2 Clinical Trial of Cynata’s Cymerus™ MSCs in Patients with Osteoarthritis
MELBOURNE, Australia, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to announce that...
-
MELBOURNE, Australia, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specializing in cell therapeutics, is pleased to announce that...
-
Positive results in preclinical models support the use of the Cymerus platform to target various cancers MELBOURNE, Australia, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX:...
-
• Cymerus MSCs demonstrate substantial protection against CRS symptoms, a serious adverse reaction caused by cancer immunotherapies such as CAR-T MELBOURNE, Australia, Sept. 19, 2018 (GLOBE...
-
MELBOURNE, Australia, Aug. 30, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX: CYP) is pleased to announce that CYP-001, its lead...
-
MELBOURNE, Australia, June 21, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce positive safety and...
-
MELBOURNE, Australia, June 12, 2018 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company Cynata Therapeutics Limited (ASX:CYP) is pleased to announce positive safety and...